SCHEMBL6188924

SCHEMBL6188924

Cc1[nH]c2ccc(N)cc2c1C(=O)c1c(F)cccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 3/20 0.39
POLB P06746 1/20 0.39
MAPK7 Q13164 2/20 0.39
MAPT P10636 6/20 0.38
HTT P42858 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPC1 O15118 2/20 0.38
MAPK1 P28482 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 2/20 0.38
PKM P14618 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CDK4 P11802 3/20 0.37
CDK2 P24941 3/20 0.37
MAOB P27338 1/20 0.37
CDK1 P06493 1/20 0.37
RORB Q92753 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188992 0.91 ALDH1A1 (0.41) LMNAGAAPOLBMAPTKMT2A
SCHEMBL6185980 0.91 LMNA (0.41) LMNASMN1; SMN2GAAMAPTHTT
SCHEMBL6185751 0.84 AR (0.45) SMN1; SMN2GAAMAPTALDH1A1CDK4
SCHEMBL6189554 0.82 ALDH1A1 (0.46) LMNAGAAPOLBMAPTMEN1
SCHEMBL6187433 0.79 MAOB (0.43) LMNASMN1; SMN2GAAPOLBMAPK7
SCHEMBL6187153 0.77 MAOB (0.45) SMN1; SMN2GAAPOLBMAPTNPC1
SCHEMBL6188627 0.77 MAOB (0.47) SMN1; SMN2MAPTNPC1RAB9AALDH1A1
SCHEMBL6191071 0.77 TUBB1 (0.44) LMNAGAAPOLBMAPTMEN1
SCHEMBL6186848 0.76 MAOB (0.49) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6187040 0.75 NGFR (0.42) LMNASMN1; SMN2GAAPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed